ASP4901 + Tamsulosin + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Benign Prostate Hyperplasia
Conditions
Benign Prostate Hyperplasia
Trial Timeline
Jul 22, 2013 → Apr 4, 2014
NCT ID
NCT02038868About ASP4901 + Tamsulosin + Placebo
ASP4901 + Tamsulosin + Placebo is a phase 2 stage product being developed by Astellas Pharma for Benign Prostate Hyperplasia. The current trial status is completed. This product is registered under clinical trial identifier NCT02038868. Target conditions include Benign Prostate Hyperplasia.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02038868 | Phase 2 | Completed |
Competing Products
20 competing products in Benign Prostate Hyperplasia